The Mindfulness Experience
Matt opens with the session that changed his direction, a felt reconnection with his late mother, then offers a clear four-part explanation of how these medicines actually work, from neuroplasticity to the quieting of the inner narrator to their spiritual dimension.
LISTEN
Listen on the show website ↗ Watch on YouTube ↗
Episode summary
Matt opens with the experience that changed his direction: a guided psychedelic session in which he felt reconnected with his late mother. He describes it less as a vision and more as a felt sense of love and lineage, along with the recognition that he had been living afraid of death and carrying grief he had tucked away. That opening sent him back to school and into the research that became Psychedelics for Everyone, a book written so that someone without a science background could understand the material and decide for themselves.
A good part of the conversation is about how these medicines actually work. Matt walks through a four-part explanation of their effects: changes in the brain such as neuroplasticity, a quieting of the default mode network and its constant inner narrator, a dissociative or out-of-body quality, and for many people a spiritual or mystical dimension. He is careful about expectations. Rather than a fix, he frames psychedelics as a catalyst that shows a person what is possible and then hands them the daily work of practice, including meditation and integration.
He also shares bringing his sixteen-year-old son to a retreat, where the teenager chose to help rather than participate, and later told the group that his father had become more emotionally available to him.
The second half turns to law and access. Matt lays out three approaches that often get conflated: a medical model regulated by the state, decriminalization of plant medicines, and a religious or sacramental model seeking exemptions under religious freedom protections. He notes how rarely such religious exemptions have actually been granted. He contrasts current antidepressants, which he says fail a large share of patients and carry heavy side effects, with early clinical results for MDMA and psilocybin, and makes the case for access while still emphasizing preparation and safer practice. The two close on common ground, including a shared experience of growing up in both Jewish and Catholic families and what that taught each of them about belonging and belief.